Nuvilex, Inc.’s (OTCQB: NVLX) stock volume continued to soar Apr. 3, with 25,542,125 shares changing hands, nearly double its three-month average volume of 12,823,479 shares.
The two-day-in-a-row surge in stock volume came only a few days after the Silver-Spring, Md.-based biotech company announced that it has signed a Master Services Agreement with Translational Drug Development in which the company will conduct preclinical and clinical studies in support of the development of Nuvilex's pancreatic cancer and other treatments utilizing Cell-in-a-Boxtechnology.
To Work With Dr. Daniel Von Hoff
In addition, Nuvilex announced that would be working with Dr. Daniel Von Hoff, a leading figure in pancreatic cancer, to develop its pancreatic cancer and other treatments utilizing its Cell-in-a-Box(R) technology. These are just the latest of several upbeat press releases from the company that is working on optimizing the anticancer effectiveness of cannabinoids.
Gets $2 Million in Initial Funding
On Feb. 24, the company announced that Lincoln Park Capital purchased 8 million in restricted shares of Nuvilex in exchange for an initial $2 million out of $27 million set aside to advance the company's late-phase pancreatic cancer clinical trials.
Over the last year Nuvilex has issued a bevy of positive press releases about how it is positioning itself and recruiting and hiring the top researchers in the medical-marijuana field. But so far, the company has not produced any concrete products or services for the industry. Neville’s cannabis business appears to still be in the developmental stage. Still, it has hired the brain power that eventually could make it a real player.
On Apr. 4, NVLX’s share price closed at 41 cents, down 4 cents from its close of 45 cents the previous day.
Sign up today for timely and hot stock alerts here, or by cutting and pasting the following link in your Web browser:
Enertopia Corp. Raises $179,450 More from Stock Warrants
In other news, Enertopia Corp.’s (OTCQB: ENRT) share volume also enjoyed robust volume Apr.4 , with 1,346,752 shares changing hands, significantly higher than its three-month average volume of 1,028,070 shares.
The upsurge in volume is being fueled in part by the Vancouver, BC-based medical marijuana company’s Apr. 3 announcement that 1,293,500 stock warrants have been exercised raising $177,950 and a further 25,000 options have been exercised for $1,500 for total consideration of $179,450 in net proceeds.
Social-Media and Marketing Manager’s Contract Continued
Enertopia also announced that it is renewing Stuart Gray’s three-month contract on Social Media and Marketing. Gray has been in the social media business for well over a decade in various capacities for publically listed companies. As an expert in media relations, and marketing awareness Enertopia looks forward to getting our news and growing story out to a broad base of investors and media.
He will be paid $5000 a month for three months and has been granted 100,000 Stock Options.
"These are exciting times for Enertopia and we look forward to further updates shortly with exceptional opportunities for our company in the Medical Marihuana Business sector," stated Enertopia’s President / CEO Robert McAllister, in a written statement.
On Apr. 4, ENRT’s share price closed at 51 cents, down 2 cents from its closing price of 53 cents the previous day.
Stevia Corp. Stock Volume Continues to Soar
Meanwhile, Farm-management company Stevia Corp. (OTCQB: STEV) also experienced heavy share volume Apr. 4, with 2,704,633 shares changing hands, substantially higher than its three-month average volume of 2,191,287 shares.
Stevia’s stock volume has been up since the Indianapolis-based company announced that it registered a wholly-owned subsidiary, Real Hemp LLC, an Indiana limited liability company.
At the same time, Stevia filed a federal trademark registration for "Real Hemp" and secured the "RealHemp.com" domain as part of its strategy to enter the United States’ hemp industry and become an importer, manufacturer and licensor of hemp products and hemp derivatives.
Hemp products can all be legally imported and traded in the United States and recent growth is being fueled by an increasingly educated public that is becoming aware of the many benefits of hemp. The 2012 retail value of North American hemp food, vitamin and body care products was estimated to be in the range of $156 to $171 million by the Hemp Industries Association (HIA).
When clothing, auto parts, building materials and other non-food or body care products are included, the HIA estimates that the total retail value of U.S. hemp products is about $500 million. Food and fiber uses for industrial hemp are growing rapidly and have increased over 300 percent, to an estimated 25,000 products, in the past few years. Much of that growth is coming from the increased sales of hemp food products.
Industrial hemp was the most important non-food crop in the early history of the United States, being used for sails, riggings, canvas, ropes, clothing and paper. Its diverse uses made it a required crop, for farmers' and the country's existence. With the passage of the Marijuana Tax Act in 1938, hemp production in the United States essentially ended. This was followed by the 1950's anti-drug legislation that made it illegal to grow any cannabis plant varieties to improve drug enforcement of illegal marijuana production.
On Apr. 4, STEV’s share price closed at 28 cents, unchanged from its close the previous day.
Pennypickalerts.com issues momentum alerts on stocks that can provide gains to day traders.
Pennypickalerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more.
Pennypickalerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Pennypickalerts.com is often in the know of several large investor awareness campaigns being deployed. Timing is everything when trading Penny Stocks. Gain an Edge by joining the Pennypickalerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Pennypickalerts.com believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership. Simply sign up for free and start receiving exclusive alerts. Subscribe Here: http://www.pennypickalerts.com
Pennypickalerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always own due diligence with any potential investment.